Obsidian Therapeutics, Inc. Common Stock OBX
$13.87
+44.43%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $39.00
- Implied Upside
- +181.3%
- Price Target Range
- $32.00 – $43.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-22 | Leerink Partners |
Initiates coverage on | Outperform | $32 |
| 2026-09-09 | William BlairSami Corwin |
Initiates coverage on | Outperform | — |
| 2026-08-18 | LifeSci Capital |
Initiates coverage on | Outperform | $43 |
| 2026-08-05 | Piper SandlerKelsey Goodwin |
Initiates coverage on | Overweight | $42 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $13.87
- Market Cap
- $593.02 million
- 52-Week Range
- $9.60 – $49.97
- Average Volume
- 447K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.